Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506)
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (2) , 345-352
- https://doi.org/10.1067/mai.2001.112600
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- FcεRI-expressing antigen-presenting cells: new players in the atopic gameImmunology Today, 1997
- FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the
G 0G 1Journal of Dermatological Science, 1996 - FK506 in the treatment of inflammatory skin disease: promises and perspectivesImmunology Today, 1996
- The skin immune system: progress in cutaneous biologyImmunology Today, 1993
- Effects of Chloroquine on Antigen-Presenting Functions of Epidermal Cells from Normal and Psoriatic SkinJournal of Investigative Dermatology, 1992
- Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In VitroJournal of Investigative Dermatology, 1991
- Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymusProtein Journal, 1991
- EFFECTS OF COMBINATION TREATMENT WITH FK506 AND CYCLOSPORINE ON SURVIVAL TIME AND VASCULAR CHANGES IN RENAL-ALLOGRAFT-RECIPIENT DOGSTransplantation, 1989
- Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in ratsInternational Journal of Immunopharmacology, 1988